A detailed history of Kbc Group Nv transactions in Legend Biotech Corp stock. As of the latest transaction made, Kbc Group Nv holds 13,144 shares of LEGN stock, worth $527,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,144
Previous 13,144 -0.0%
Holding current value
$527,600
Previous $582,000 10.14%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$55.06 - $69.99 $153,452 - $195,062
-2,787 Reduced 17.49%
13,144 $737,000
Q4 2023

Feb 13, 2024

SELL
$57.25 - $69.74 $24,045 - $29,290
-420 Reduced 2.57%
15,931 $959,000
Q3 2023

Feb 15, 2024

SELL
$63.16 - $76.5 $59,496 - $72,063
-942 Reduced 5.76%
15,409 $1.04 Million
Q2 2023

Feb 15, 2024

SELL
$46.28 - $75.01 $199,374 - $323,143
-4,308 Reduced 20.85%
16,351 $1.13 Million
Q2 2023

Jul 28, 2023

SELL
$46.28 - $75.01 $46,280 - $75,010
-1,000 Reduced 5.76%
16,351 $0
Q1 2023

Feb 14, 2024

SELL
$43.42 - $57.37 $52,104 - $68,844
-1,200 Reduced 6.47%
17,351 $837,000
Q1 2023

May 04, 2023

SELL
$43.42 - $57.37 $143,633 - $189,779
-3,308 Reduced 16.01%
17,351 $0
Q4 2022

Feb 14, 2024

SELL
$38.8 - $55.46 $132,579 - $189,506
-3,417 Reduced 15.55%
18,551 $926,000
Q3 2022

Feb 15, 2024

BUY
$38.15 - $57.1 $180,373 - $269,968
4,728 Added 29.68%
20,659 $843,000
Q3 2022

Nov 08, 2022

SELL
$38.15 - $57.1 $49,938 - $74,743
-1,309 Reduced 5.96%
20,659 $843,000
Q2 2022

Feb 14, 2024

SELL
$33.54 - $55.0 $365,485 - $599,335
-10,897 Reduced 33.16%
21,968 $1.21 Million
Q2 2022

Jul 26, 2022

SELL
$33.54 - $55.0 $365,485 - $599,335
-10,897 Reduced 33.16%
21,968 $1.21 Million
Q1 2022

Feb 14, 2024

BUY
$31.02 - $48.18 $218,225 - $338,946
7,035 Added 27.24%
32,865 $1.19 Million
Q1 2022

May 06, 2022

BUY
$31.02 - $48.18 $218,225 - $338,946
7,035 Added 27.24%
32,865 $1.19 Million
Q4 2021

Feb 14, 2024

BUY
$41.14 - $56.98 $407,244 - $564,045
9,899 Added 62.14%
25,830 $1.2 Million
Q4 2021

Feb 03, 2022

BUY
$41.14 - $56.98 $234,580 - $324,899
5,702 Added 28.33%
25,830 $1.2 Million
Q3 2021

Nov 10, 2021

SELL
$35.31 - $50.56 $251,619 - $360,290
-7,126 Reduced 26.15%
20,128 $1.02 Million
Q1 2021

Apr 26, 2021

BUY
$23.55 - $32.4 $126,816 - $174,474
5,385 Added 24.62%
27,254 $791,000
Q4 2020

Feb 10, 2021

SELL
$25.8 - $32.39 $1.17 Million - $1.47 Million
-45,297 Reduced 67.44%
21,869 $616,000
Q3 2020

Oct 28, 2020

BUY
$27.5 - $39.61 $1.85 Million - $2.66 Million
67,166 New
67,166 $2.07 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.72B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.